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Abstract The effect of the in vivo thyroid status on mitochon-
drial membrane potential (v8m) in isolated rat hepatocytes was
studies by means of a cytofluorimetric technique and the v8m-
specific probe JC-1. It is shown that the v8m level decreases in
the order hypothyroids euthyroids hyperthyroid. Polaro-
graphic measurement of the hepatocyte respiratory rates
revealed an opposite trend of values: the highest respiratory
rate in hepatocytes from hyperthyroid animals, the lowest in
those from hypothyroid ones. This means that mitochondrial
energy coupling is highest in hypothyroid hepatocytes and lowest
in hyperthyroid hepatocytes. 6-Ketocholestanol added to hepa-
tocytes failed to counterbalance the uncoupling effect of thyroid
hormones on v8m and respiration rate. Under the same
conditions, 6-ketocholestanol appeared to be effective in
recoupling of respiration uncoupled by low concentrations of
the artificial protonophore FCCP. The mechanism and possible
physiological functions of the thyroid hormone-induced decrease
in mitochondrial energy coupling are discussed.
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1. Introduction
Stimulation of metabolic rate and decrease in its e⁄ciency
by thyroid hormones has been known for many years. The
calorigenic e¡ect of these hormones was ¢rst described as
early as 1895 [1]. Martius and Hess [2] postulated that uncou-
pling of respiration and phosphorylation is involved in this
e¡ect and showed that thyroxine added to mitochondria in
vitro caused uncoupling. Unfortunately, the hormone concen-
trations required for the e¡ect were many orders of magnitude
higher than those present in vivo (see also [3]). As for mito-
chondria isolated from hyperthyroid animals, they showed, as
a rule, lowered energy coupling which could be explained by a
lower resistance of these mitochondria to damage during or-
ganelle isolation. In 1956 Beyer et al. concluded that in vitro
aging of mitochondria ‘‘reveals that the di¡erence between the
thyxine-treated and normal animals is the degree of lability of
the oxidation-phosphorylation system’’ [4].
The discussion on whether thyroid hormone-induced un-
coupling is (i) a physiological phenomenon, (ii) a pathology
related to hyperproduction of the hormones, or (iii) an in
vitro artifact has continued for almost half a century. Only
quite recently, some observations were published that cannot
be explained by an artifact. Lanni et al. [5] and Masaki et al.
[6] have shown that thyroid hormones in vivo strongly in-
crease the level of mRNA of uncoupling protein 2 in some
tissues. Uncoupling protein 2 (UCP2) [7^9] has a similar (but
not identical) sequence to uncoupling protein 1 (thermogenin)
found in brown fat where it is responsible for thermoregula-
tory uncoupling (for review, see [10]). The UCP-2 mRNA
level in rat heart, skeletal muscle and brown fat increases
during 48 h exposure to 6‡C [11]. This points to the involve-
ment of UCP2 in thermoregulatory uncoupling occurring not
only in brown fat but also in muscle tissues [12^14]. Independ-
ently, Gong et al. [15] and Larkin et al. [16] reported that the
mRNA level of another member of the UCP family, UCP3
[8,17], is strongly increased by thyroid hormones in brown fat
and skeletal muscles. Cold exposure was also e¡ective in
brown fat but not in muscle [17]. The very fact that thyroid
hormones induce UCP2 and UCP3 strongly suggests that un-
coupling is inherent in their in vivo e¡ects.
UCP2 mRNA is found in many tissues except in hepato-
cytes [7^9,18]. As for UCP3 mRNA, it is speci¢c for brown
fat and muscle. Nonetheless, Gregory and Berry have ob-
served a decrease in v8m in hepatocytes from hyperthyroid
rats [19]. This observation was con¢rmed by Harper and
Brand [20]. According to Brand and coworkers [21], proton
conductance of the mitochondrial membrane in hepatocytes
from hypothyroid animals is decreased compared with euthy-
roid controls. The same group failed to observe any v8m
increase in hypothyroid hepatocytes although hyperthyroid
ones showed an obvious v8m decrease [20].
In the present paper, a cyto£uorimetric method developed
to follow v8m [22^27] was used to study isolated living hep-
atocytes. The method employs the lipophilic penetrating cat-
ion JC-1 as a v8m probe. The cation accumulates electro-
phoretically in the v8m-bearing mitochondria. When the
intramitochondrial concentration of JC-1 increases, the cation
forms J-aggregates. This results in a large shift of £uorescence
emission (from 527 nm to 590 nm) [25^27]. The experiments
revealed that euthyroid hepatocytes show a lower mitochon-
drial membrane potential and a higher respiration rate than
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hypothyroid ones. Hyperthyroidism was found to entail fur-
ther membrane potential decrease and respiration increase.
2. Materials and methods
Male rats, Sprague-Dawley strain, pathogen germ free, weighing
180^200 g were used. Animals were maintained on a 12-h light-dark
cycle at 21‡C and were provided with standard rat chow diet and
water ad libitum. Rats were killed by decapitation for preparation
of mitochondria, or operated under Ketalar (Parke-Davis, Italy) anes-
thesia (0.2 ml/100 g wet weight) for hepatocyte isolation. Hyperthyr-
oidism was induced by subcutaneous injections for 2^3 days of 0.5 mg/
100 g 3,5,3P-triiodothyronine (T3) dissolved in a minimal amount of
0.01 N NaOH and diluted with saline to 1 mg/ml. Control rats were
injected with 0.9% NaCl solution. On the day of the experiment, the
rats were given the last dose of T3 at 9.00 h and were killed 1 h later.
Hypothyroidism was induced with 0.02% methimazole added to the
drinking water for 8^10 days [28]. In order to check whether the
treated rats changed their thyroid state, the rate of mitochondrial
respiration was measured using K-glycerol phosphate as respiratory
substrate since the activity of mitochondrial K-glycerol phosphate de-
hydrogenase (EC 1.1.99.5) is known to strictly correlate with the
thyroid state of animals [29]. Mitochondria were prepared as de-
scribed by Bobyleva et al. [30] from 10% total liver homogenate.
Mitochondrial respiration was measured at 30‡C in a medium of
the following composition: 100 mM KCl, 10 mM MgCl2, 10 mM
Tris-HCl, 10 mM Na,K phosphate bu¡er, pH 7.4, 10 mM DL-K-glyc-
erol phosphate and 3 WM rotenone. It was shown that mitochondria
from methimazole-treated, non-treated, and T3-treated rats oxidized
DL-K-glycerol phosphate in state 3 at rates of 1.8, 6.6 and 17.7 ng
atom O/(mg proteinUmin), respectively.
Hepatocytes were prepared according to Krebs [31] using in situ
liver perfusion with collagenase. 10 mM glucose was added to the
perfusion medium. Isolated and washed hepatocytes were suspended
(3^5U107 cells/ml) in Krebs-Henseleit medium supplemented with 33
mM HEPES and 10 mM glucose, pH 7.4 (suspension medium). As
distinguished from the Krebs protocol, 2.5% dialyzed albumin was
added to cells only during their washing, and the ¢nal suspension
was kept in the medium without albumin. Hepatocytes were kept in
small portions (1^2 ml) in tubes on ice. At the end of the preparation,
cell viability was checked with the trypan blue (0.3% w/v) exclusion
test. Only cells with viability higher than 90% were used for experi-
ments.
Oxygen consumption was recorded with a Clark-type oxygen elec-
trode and ESI polarograph (Italy). Hepatocytes were incubated in the
suspension medium supplemented with 1.3 WM oligomycin, 10 mM
lactate and 1 mM pyruvate. Hepatocyte concentration was 1U106
cells/ml. The total volume of the £ask was 3 ml. The measurements
were done at 37‡C.
The electrical potential di¡erence across inner mitochondrial mem-
brane in isolated hepatocytes (v8m) was monitored using cyto£uorim-
etry and the v8m-speci¢c £uorescent probe JC-1. 107 fresh hepato-
cytes were suspended in the suspension medium at a concentration of
106 cells/ml and incubated for 10 min at room temperature in the dark
with 10 WM JC-1. Cells were washed twice with the suspension me-
dium and ¢nally resuspended in a total volume of 10 ml. At this stage,
the viability of cells decreased slightly, but was always higher than
85%. Hepatocytes obtained were stored on ice. A portion of cells
(5 ml) was treated with 1.3 WM oligomycin, 10 mM lactate and
1 mM pyruvate in a shaking bath at 37‡C. After 3 min treatment,
1 ml hepatocyte suspension was collected and analyzed. The analysis
was performed using a FACScan £ow cytometer (Becton Dickinson,
San Jose, CA), equipped with a single 488 nm argon laser. The values
of the photomultiplier (PMT) detecting the signal on £uorescence
channel 1 (FL1) and channel 2 (FL2) were set at 250 and 240 V,
respectively; the FL1-FL2 compensation was 1.0%, the FL2-FL1
compensation was 44.5%. A minimum of 10 000 cells per sample
was acquired in list mode and analyzed with Lysys II software (Bec-
ton Dickinson), as described by Cossarizza et al. [32] and Polla et al.
[33]. Fluorescent histograms are shown in a linear scale to allow the
correct detection of the median £uorescence channel. Cells with a high
v8m are those showing high red £uorescence due to the formation of
J-aggregates.
Protein concentration was measured by the biuret method [34] with
bovine serum albumin as the reference.
Enzymes and coenzymes were purchased from Boehringer-Mann-
heim (Germany); rotenone, oligomycin, methimazole, 6-ketocholes-
tanol, and FCCP were from Sigma. JC-1 was from Molecular Probes
(Eugene, OR, USA). FCCP, rotenone, oligomycin, 6-ketocholestanol
were dissolved in 95% ethanol. JC-1 was dissolved in DMPA (Sigma).
3. Results and discussion
Table 1 shows the respiration rates of isolated rat liver
mitochondria and hepatocytes treated with oligomycin (so-
called state 4 respiration, left column). These rates increased
with the increase of thyroid status (hypothyroid6 euthy-
roid6 hyperthyroid). The recoupler 6-ketocholestanol (kCh)
failed to abolish the thyroid hormone-induced increase in
the respiration rate. Addition of a low concentration of the
protonophorous uncoupler FCCP was stimulatory in all cases.
In line with previous observations [35,36], this stimulation was
abolished by the recoupler kCh; in mitochondria, a higher
FCCP concentration completely released the kCh inhibition.
Fig. 1 demonstrates the results of the experiments where
v8m was measured by cyto£uorimetry using the JC-1 probe.
The left shift of the peak indicates a v8m decrease [24^26]. It
is shown that hypothyroidism enhanced and hyperthyroidism
lowered the v8m level. Addition of kCh failed to prevent the
thyroid hormone-induced v8m lowering. As for high FCCP,
kCh was more e⁄cient in the v8m decrease in euthyroid
hepatocytes compared with hypothyroid ones.
Fig. 2 shows that kCh was competent in recoupling of
mitochondria in the euthyroid hepatocytes treated with low
FCCP. This means that the lack of a kCh e¡ect on the thyroid
hormone-induced uncoupling in the euthyroid hepatocytes
cannot be accounted for by inability of kCh to reach mito-
chondria in intact cells.
In both hypo- and hyperthyroid hepatocytes, uncoupling by
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Table 1
E¡ect of thyroid status, 6-ketocholestanol, and FCCP on isolated mitochondria and hepatocytes in the presence of oligomycin
Subject Thyroid state No addition kCh Low FCCP Low FCCP+kCh High FCCP+kCh
Mitochondria Hypothyroid 10.9 þ 3.6 29.2 þ 3.9 12.6 þ 3.9 42.1 þ 15.8
Euthyroid 22.5 þ 6.0 47.8 þ 12.8 24.6 þ 6.6 54.6 þ 11.2
Hyperthyroid 31.3 þ 2.1 59.9 þ 7.0 31.0 þ 3.4 64.1 þ 11.9
Hepatocytes Hypothyroid 18.4 þ 2.0 15.1 þ 3.0 24.9 þ 1.1 17.9 þ 2.3 22.9 þ 3.8
Euthyroid 25.8 þ 2.3 25.0 þ 2.6 35.7 þ 3.3 26.8 þ 2.5 30.8 þ 3.5
Hyperthyroid 33.3 þ 1.9 29.6 þ 4.6 49.3 þ 5.9 31.8 þ 3.2 29.8 þ 2.8
Figures represent means þ S.D.
Mitochondria were incubated with 5 mM succinate, 3U1036 M rotenone and 1.3U1036 M oligomycin. For other conditions, see Section 2.
Additions: low FCCP, 40 nM for mitochondria and 60 nM for cells; 0.08 mM kCh; high FCCP, 180 nM for mitochondria, 240 nM for hypo- and
euthyroid cells, 120 nM for hyperthyroid cells. Respiration rates are expressed as ng atom O/(mg proteinUmin) or ng atom O/(106 cellsUmin) for
mitochondria or cells, respectively.
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low FCCP and, hence, recoupling by kCh were less clearcut
than in the euthyroid ones. This is probably due to the facts
that (i) thyroid hormones were shown to facilitate uncoupling
by FCCP [37] so under hypothyroid conditions the e¡ect of
low FCCP is small, and (ii) hyperthyroidism per se results in
such a strong uncoupling that the JC-1 probe responds only
slightly to low FCCP.
The above data clearly show that some decrease in the
mitochondrial energy coupling is inherent not only in the
hyper- but also in the euthyroid state. In fact, in euthyroid
hepatocytes the respiration rate is higher but v8m is lower
than in hypothyroid hepatocytes. This means that a certain
lowering of the energy coupling by thyroid hormones should
be considered a physiological e¡ect rather than a pathology
caused by hormone overproduction. In this context, it should
be mentioned that Harper and Brand [20] failed to observe
any v8m decrease in euthyroid hepatocytes compared with
hypothyroid ones. This discrepancy is probably a result of
the di¡erent methods employed to measure v8m (JC-1 and
TPP in our and Harper and Brand’s experiments, respec-
tively). An investigation carried out in our group [22] showed
that JC-1 monitors the v8m level more adequately in intact
cells, although in isolated mitochondria the TPP probe is
quite good [38].
In cells other than hepatocytes, the thyroid hormone-in-
duced decrease in the energy coupling may be due to induc-
tion of proteins belonging to the UCP family [5,6,15,16]. Ap-
parently UCPs operate as transmembrane carriers of fatty
acid anions, facilitating in this way the H-conducting fatty
acid cycle: protonated fatty acids di¡use to the mitochondrial
matrix via lipid parts of the membrane whereas their anions
are electrophoretically expelled in the opposite direction via
UCP [10,39]. However, UCPs are absent from hepatocytes
[7,8,18] so other mechanisms to decrease the energy coupling
should be considered.
One of them may be that in hepatocytes, the ATP/ADP
antiporter substitutes for UCP as the fatty acid anion trans-
locator. In this group, it was shown that the antiporter medi-
ates the uncoupling e¡ect of fatty acids in mitochondria
[14,39,40] and proteoliposomes [41] (see also [42]). On the
other hand, it is known that thyroid hormones increase the
level of the ATP/ADP antiporter in hepatocytes [43^45]. A
correlation of the uncoupling e⁄ciency of fatty acids and
the amount of the ATP/ADP antiporter was revealed by
Schunfeld when mitochondria from various tissues di¡ering
in antiporter content were compared [46]. Thus the thyroid
hormone-induced uncoupling in liver can be explained by a
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Fig. 2. 6-Ketocholestanol recouples hepatocytes uncoupled with low
concentrations of FCCP. For conditions, see Fig. 1. A, no addi-
tions; B, 60 nM FCCP; C, 60 nM FCCP and 80 WM kCh; D, 240
nM FCCP and 80 WM kCh.
Fig. 1. Thyroid hormones induce a decrease of v8m in hepatocytes
in a 6-ketocholestanol-resistant fashion. Representative £uorescence
distribution from histogram of JC-1-stained hepatocytes treated with
oligomycin. One experiment out of ¢ve for each thyroid state is
shown. A, no additions; B, 80 WM kCh; C, 80 WM kCh and 240
nM FCCP.
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hormone-induced increase in the ATP/ADP antiporter con-
centration, entailing elevation of mitochondrial proton con-
ductance mediated by free fatty acids. In fact, there are in-
dications of an in vivo increase in H conductance of the
mitochondrial membrane by thyroid hormones [21,47,48]. Re-
cently, Schunfeld et al. [49] reported that expression of the
ATP/ADP antiporter in liver mitochondria parallels the in-
crease in their sensitivity to uncoupling e¡ect of fatty acids.
It should be emphasized that the thyroid hormone-linked
uncoupling in hepatocytes proved to be kCh-resistant like
uncoupling caused by fatty acids and in contrast to that
caused by low concentrations of FCCP-like uncouplers [36].
Thus one can conclude that this uncoupling is mediated
mainly by fatty acids or by another endogenous uncoupler
which is also kCh-resistant. As for a thyroid hormone-related
uncoupling mechanism which can be abolished by kCh [37], if
it exists, it plays only a minor role in hepatocytes.
It is not excluded that a decrease in the energy coupling by
thyroid hormones in the liver tissue is related, to some degree,
to the so called decoupling, i.e. a decrease in H pump e⁄-
ciency of the respiratory chain, rather than to an increase in
dissipation of the proton motive force due to elevated H
conductance. The molecular mechanism of decoupling is ob-
scure. One can ¢nd in the literature some speculations that it
is decoupling that is responsible for some e¡ects of thyroid
hormones on mitochondria [50] (see, however, [51]).
The physiological role of a decrease in energy coupling
caused by thyroid hormones in euthyroid animals may be
related to (i) thermoregulation [10,14], (ii) metabolic functions
of respiration (i.e. respiration-linked interconversions of some
substances) [10,14], and (iii) antioxidant defence [18,52]. In all
these cases, tight coupling may be undesirable (for discussion,
see [14]).
Another e¡ect of thyroid hormones consists in an increase
in amount and activity of the respiratory chain enzymes (re-
viewed by Soboll [48], see also [53]). However, this phenom-
enon is not su⁄cient to explain the v8m decrease caused by
thyroid hormones.
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